MarketCap
Facebook
X
TelegramLuminex Corporation Market Cap 2011-2026 | LMNX
As of May 15, 2026 Luminex Corporation has a market cap of $ 1.75 B
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap Luminex Corporation
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 1.27 B | 1.02 B | 1.21 B | 868 M | 832 M | 808 M | 733 M | 759 M | 742 M | 818 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.27 B | 733 M | 906 M |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Medical instruments industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
The Cooper Companies
COO
|
16.3 B | $ 60.38 | - | $ 12 B |  USA |
 |
Atrion Corporation
ATRI
|
639 M | - | - | $ 810 M | USA |
 |
Repro Med Systems
KRMD
|
199 M | $ 3.98 | - | $ 184 M | USA |
 |
ICU Medical
ICUI
|
3.67 B | $ 122.99 | 0.78 % | $ 3.03 B | USA |
 |
iRhythm Technologies
IRTC
|
5.08 B | $ 114.16 | - | $ 3.65 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
809 K | - | -9.52 % | $ 20.6 M | USA |
 |
Intuitive Surgical
ISRG
|
171 B | $ 428.06 | - | $ 153 B | USA |
 |
Alcon
ALC
|
42.6 B | $ 64.0 | -0.03 % | $ 40.4 B |  Schweiz |
 |
LeMaitre Vascular
LMAT
|
2.54 B | $ 99.5 | - | $ 2.25 B | USA |
 |
Masimo Corporation
MASI
|
8.96 B | $ 178.35 | - | $ 9.51 B | USA |
 |
Antares Pharma, Inc.
ATRS
|
727 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
2.27 B | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
152 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
6.07 B | - | -0.05 % | $ 10.3 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
26.1 M | - | - | $ 28.6 M | USA |
 |
Envista Holdings Corporation
NVST
|
4.83 B | $ 23.86 | - | $ 4.01 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
15.6 B | - | -0.02 % | $ 16.3 B | USA |
 |
electroCore
ECOR
|
55.6 K | $ 6.43 | - | $ 54.5 K | USA |
 |
Haemonetics Corporation
HAE
|
3.06 B | $ 57.12 | - | $ 2.87 B | USA |
 |
Isoray
ISR
|
24.5 M | - | 0.03 % | $ 108 M | USA |
 |
STAAR Surgical Company
STAA
|
941 M | $ 32.01 | - | $ 1.59 B | USA |
 |
Glaukos Corporation
GKOS
|
4.3 B | $ 142.15 | - | $ 6.88 B | USA |
 |
STERIS plc
STE
|
24.2 B | $ 215.98 | - | $ 21.3 B | USA |
 |
Teleflex Incorporated
TFX
|
5.44 B | $ 130.28 | - | $ 5.81 B | USA |
 |
InfuSystem Holdings
INFU
|
117 M | $ 8.61 | - | $ 178 M | USA |
 |
Microbot Medical
MBOT
|
120 M | $ 1.85 | - | $ 84.7 M |  Israel |
 |
Milestone Scientific
MLSS
|
23.8 M | $ 0.34 | -0.87 % | $ 27.9 M | USA |
 |
Merit Medical Systems
MMSI
|
4.85 B | $ 62.56 | - | $ 3.7 B | USA |
 |
Utah Medical Products
UTMD
|
199 M | $ 63.7 | - | $ 206 M | USA |
 |
West Pharmaceutical Services
WST
|
17.6 B | $ 300.19 | - | $ 21.7 B | USA |
 |
Pulse Biosciences
PLSE
|
1.7 B | $ 27.1 | - | $ 1.83 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
2.52 B | $ 10.41 | - | $ 2.08 B | USA |
 |
Retractable Technologies
RVP
|
20.1 M | $ 0.69 | 0.01 % | $ 20.7 M | USA |
 |
Pro-Dex
PDEX
|
150 M | $ 58.65 | - | $ 193 M | USA |
 |
Predictive Oncology
POAI
|
553 K | - | - | $ 31.1 M | USA |
 |
BioLife Solutions
BLFS
|
988 M | $ 21.06 | - | $ 1.01 B | USA |
 |
Stereotaxis
STXS
|
171 M | $ 1.94 | - | $ 176 M | USA |
 |
Baxter International
BAX
|
9.65 B | $ 17.78 | - | $ 9.12 B | USA |
 |
ResMed
RMD
|
35.1 B | $ 202.46 | - | $ 29.6 B | USA |
 |
AtriCure
ATRC
|
1.56 B | $ 28.15 | - | $ 1.34 B | USA |
 |
Harvard Bioscience
HBIO
|
20.9 M | $ 5.52 | - | $ 245 M | USA |
 |
NeuroMetrix
NURO
|
8.71 M | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
355 M | $ 11.03 | - | $ 451 M | USA |
 |
Becton, Dickinson and Company
BDX
|
56.2 B | $ 144.47 | - | $ 41.6 B | USA |
 |
Nephros
NEPH
|
33.2 M | $ 3.34 | - | $ 35.4 M | USA |
 |
OraSure Technologies
OSUR
|
235 M | $ 2.95 | - | $ 217 M | USA |
 |
Repligen Corporation
RGEN
|
6.67 M | $ 103.38 | - | $ 5.81 M | USA |